InvestorsHub Logo
Followers 32
Posts 10384
Boards Moderated 0
Alias Born 04/20/2016

Re: kwazeetech1 post# 2495

Wednesday, 02/01/2017 7:07:06 PM

Wednesday, February 01, 2017 7:07:06 PM

Post# of 5001
I don't see message board posters pumping this. The heavier selling volume might be attributed to the entanglement with Platinum Partners. Eventually that selling will cease.

I have met CEO, pretty impressed with all the vendors they contracted for trials. Interesting Trump comments regarding streamlining the FDA process. They also have all top notch people on the Boards.

This is a biotech and obviously carries that risk, but it is also ground level even though the Company has been around for years. This is about as ground floor as you can get. Allergen laid out 600m upfront with 1 bill on the backend if theirs is approved. There is a need for a new depression drug. IMO this is a 24 month hold. The Bayer joint venture is intreresting also.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VTGN News